Publikationen, an denen er mitarbeitet Leonel Pekarek (32)

2024

  1. A comprehensive study of the academic benefits and practical recommendations to include resistance training programs in institutional education

    Frontiers in Psychology, Vol. 15

  2. Decreased survival in patients with pancreatic cancer may be associated with an increase in histopathological expression of inflammasome marker NLRP3

    Histology and histopathology, Vol. 39, Núm. 1, pp. 35-40

  3. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

    Medicina (Lithuania), Vol. 60, Núm. 1

  4. Oxidative Stress, Lipid Peroxidation and Ferroptosis Are Major Pathophysiological Signatures in the Placental Tissue of Women with Late-Onset Preeclampsia

    Antioxidants, Vol. 13, Núm. 5

  5. Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer

    Current Issues in Molecular Biology, Vol. 46, Núm. 5, pp. 3839-3865

2023

  1. A Review: Integrative Perspectives on the Features and Clinical Management of Psychotic Episodes in Pregnancy

    Journal of Clinical Medicine, Vol. 12, Núm. 2

  2. An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  3. Clinical and Translational Applications of Serological and Histopathological Biomarkers in Metastatic Breast Cancer: A Comprehensive Review

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  4. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review)

    Oncology reports, Vol. 50, Núm. 6

  5. Updated Views in Targeted Therapy in the Patient with Non-Small Cell Lung Cancer

    Journal of Personalized Medicine, Vol. 13, Núm. 2

  6. Women with psychotic episodes during pregnancy show increased markers of placental damage with Tenney-Parker changes

    Histology and Histopathology, Vol. 38, Núm. 10, pp. 1109-1118

2022

  1. Clinical Applications of Classical and Novel Biological Markers of Pancreatic Cancer

    Cancers, Vol. 14, Núm. 8

  2. Clinical and Novel Biomarkers in Penile Carcinoma: A Prospective Review

    Journal of Personalized Medicine, Vol. 12, Núm. 9

  3. Exploring histopathological and serum biomarkers in lung adenocarcinoma: Clinical applications and translational opportunities (Review)

    International journal of oncology, Vol. 61, Núm. 6

  4. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

    Current Oncology, Vol. 29, Núm. 4, pp. 2442-2453

  5. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer

    Antioxidants, Vol. 11, Núm. 4

  6. Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma—A Histopathological Study

    Medicina (Lithuania), Vol. 58, Núm. 6

  7. Prognostic role of IRS-4 in the survival of patients with pancreatic cancer

    Histology and histopathology, Vol. 37, Núm. 5, pp. 449-459

  8. Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  9. Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine

    Frontiers in Oncology, Vol. 12